u/CosmikBear

Cardio 5h 21m Vascular 2h 29m Repro & GU 3h 51m MSK & Derm 2h 18m
• Chapter 1 - Ischemic Heart Disease • Chapter 1 - Atherosclerosis • Chapter 1 - Uterine & Vulvovaginal Disorders • Chapter 1 - Bone
 1.1 - Myocardial Response to Ischemia 27m  1.1 - Atherosclerosis: Pathophysiology 24m  1.1 - Abnormal Uterine Bleeding (AUB) & Endometriosis 27m  1.1 - Osteoporosis & Paget Disease of Bone 15m
 1.2 - Stable Angina, Vasospastic Angina, & Acute Coronary  1.2 - Peripheral Artery Disease 11m  1.2 - Cervical Neoplasia 20m  1.2 - Osteomalacia & Rickets 10m
Syndromes (UA, NSTEMI, STEMI) 26m • Chapter 2 - Hypertension  1.3 - Vulvar & Vaginal Lesions 12m  1.3 - Benign Bone Tumors 7m
 1.3 - Acute Myocardial Infarction & Post-MI Timeline 32m  2.1 – Hypertension 24m • Chapter 2 - Reproductive Hormones & Ovarian Disorders  1.4 - Malignant Bone Tumors 9m
• Chapter 2 - Heart Failure  2.2 - Aortic Aneurysm 23m  2.1 - Reproductive Hormones Overview & PCOS 12m  1.5 - Congenital Bone Disorders: Osteogenesis Imperfecta,
 2.1 - Congestive Heart Failure – Pathophysiology 26m  2.3 - Aortic Dissection 13m  2.3 – Amenorrhea 15m Achondroplasia & Osteopetrosis 11m
 2.2 - Congestive Heart Failure - Clinical Manifestations 24m • Chapter 3 - Vasculitides  2.3 - Ovarian Cysts & Epithelial Ovarian Cancer 14m • Chapter 2 - Joint
• Chapter 3 - Myocardial & Pericardial Disorders  3.1 - Large & Medium Vessel Vasculitides 28m  2.4 - Ovarian Neoplasms (Germ Cell & Sex Chord-Stromal  2.1 – Osteoarthritis 8m
 3.1 - Dilated and Restrictive Cardiomyopathy 23m  3.2 - Small Vessel Vasculitides 26m Tumors) 16m  2.2 - Rheumatoid Arthritis 10m
 3.2 - Hypertrophic Cardiomyopathy 19m • Chapter 3 - Gestational Disorders  2.3 - Gout & Pseudogout 14m
 3.3 – Myocarditis 14m GI 3h 51m  3.1 - Hydatidiform Mole & Choriocarcinoma 15m • Chapter 3 - Muscle
 3.4 - Pericarditis & Constrictive Pericarditis 20m • Chapter 1 - Esophageal & Gastric Disorders  3.2 - Gestational Disorders 24m  3.1 - Muscular Dystrophies 11m
• Chapter 4 - Valvular Disorders  1.1 - Structural Esophageal Disorders & GERD 19m  3.3 - Polyhydramnios & Oligohydramnios 4m  3.2 - Myasthenia Gravis & Lambert-Eaton Myasthenic
 4.1 - Mitral Stenosis, Acute Rheumatic Fever & Rheumatic  1.2 - Esophageal Dysmotility & Cancer 20m • Chapter 4 - Breast Syndrome 15m
Heart Disease 26m  1.3 - Acute and Chronic Gastritis & Peptic Ulcer Disease 33m  4.1 - Benign Breast Disorders 17m • Chapter 4 - Derm
 4.2 - Mitral Valve Regurgitation and Prolapse 20m  1.4 - Gastric Dysmotility & Cancer 16m  4.2 - Breast Cancer 19m  4.1 - Actinic Keratosis, Squamous Cell Carcinoma & Basal Cell
 4.3 - Aortic Stenosis and Regurgitation 22m • Chapter 2 - Small Bowel Disorders • Chapter 5 - Male GU Carcinoma 13m
• Chapter 5 - Congenital Heart Disease  2.1 - Small Bowel Obstruction, Ileus & Hernias 16m  5.1 - Testicular Disorders & Cancer 15m  4.2 - Malignant Melanoma 15m
 5.1 - Left-to-Right Shunts 25m  2.2 - Carcinoid Tumor & Small Bowel Neoplasms 16m  5.2 - Benign Prostatic Hyperplasia (BPH) & Prostate Cancer 10m
 5.2 - Right-to-Left Shunts 17m  2.3 - Intestinal Ischemia & Angiodysplasia 17m  5.3 - Bladder Cancer & Penile Disorders 11m Neuro 3h 31m
 2.4 - Congenital GI Disorders 23m • Chapter 1 - Cerebrovascular
Pulmonary 3h 23m • Chapter 3 - Colorectal & Anal Disorders Blood & Coag 3h 54m  1.1 - Epidural Hematoma, Subdural Hematoma, &
• Chapter 1 - Obstructive Lung Disease  3.1 - Large Bowel & Appendiceal Disorders 16m • Chapter 1 - Microcytic Anemias Subarachnoid Hemorrhage 13m
 1.1 - COPD & Emphysema 28m  3.2 - Crohn's Disease & Ulcerative Colitis 16m  1.1 - Microcytic Anemia: Overview & Thalassemias 23m  1.2 - Ischemic & Hemorrhagic Stroke 22m
 1.2 - Asthma & Bronchiectasis 19m  3.3 - Colorectal Polyps & Cancer 25m  1.2 - Iron Deficiency Anemia & Anemia of Chronic Disease 21m • Chapter 2 - Intracranial Hypertension and Tumors
• Chapter 2 - Restrictive Lung Disease  3.4 - Anorectal Disorders 14m • Chapter 2 - Normocytic & Macrocytic Anemias  2.1 - Intracranial Hypertension (ICH) 21m
 2.1 - Restrictive Lung Disease (Overview) 18m  2.1 - Extravascular Hemolysis: Overview & RBC Membrane  2.2 – Hydrocephalus 15m
 2.2 - Idiopathic Pulmonary Fibrosis 13m Hepatobiliary 3h 37m Defects 18m  2.3 - Adult CNS Tumors 20m
 2.3 – Pneumoconioses 16m • Chapter 1 - Gallbladder & Biliary Tract Disease  2.2 - Intravascular Hemolysis: Overiew & Paroxysmal Nocturnal  2.4 - Pediatric CNS Tumors 14m
 2.4 - Sarcoidosis & Berylliosis 21m  1.1 - Lab Evaluation of Liver Injury & Hyperbilirubinemia 25m Hemoglobinuria (PNH) 11m • Chapter 3 - Spinal Cord & Peripheral Nerve
• Chapter 3 - Acute Lung Disorders  1.2 - Gallbladder & Biliary Tract Disease 27m  2.3 - G6PD Deficiency & AIHA 17m  3.1 - Spinal Muscular Atrophy, Amyotrophic Lateral Sclerosis
 3.1 – Pneumothorax 18m  1.3 - Autoimmune Biliary Tract Disorders & Cancer 19m  2.4 - Sickle Cell Disease 23m (ALS) & Friedreich Ataxia 12m
 3.2 - Acute Respiratory Distress Syndrome (ARDS) 16m • Chapter 2 - Liver Disease  2.5 - Megaloblastic Anemia: Folate Deficiency & Vitamin B12  3.2 - Multiple Sclerosis 14m
 3.3 - Deep Vein Thrombosis & Pulmonary Embolism 24m  2.1 - Cirrhosis - Pathogenesis & Clinical Manifestations 30m Deficiency 24m  3.3 - Guillain-Barré & Charcot-Marie-Tooth 9m
• Chapter 4 - Lung Cancer  2.2 - Hereditary Hemochromatosis & Wilson's Disease 20m • Chapter 3 - Coagulopathies & Platelet Disorders • Chapter 4 - Congenital & Neurocutaneous
 4.1 - Lung Carcinoma 30m  2.3 - Alcoholic and Non-alcoholic Fatty Liver Disease 20m  3.1 - Quantitative Platelet Disorders 23m  4.1 - Neural Tube Defects, Holoprosencephaly, Chiari
 2.4 - Liver Tumors & Hepatocellular Carcinoma 30m  3.2 - Qualitative Platelet Disorders 14m Malformation & Syringomyelia 15m
Renal 5h 19m • Chapter 3 - Pancreatic Disease  3.3 - Inherited Coagulation Defects 18m  4.2 - Sturge-Weber & Tuberous Sclerosis 9m
• Chapter 1 - Acute Kidney Injury  3.1 - Acute & Chronic Pancreatitis 21m  3.4 - Acquired Coagulation Defects 17m  4.3 – Neurofibromatosis 7m
 1.1 - Renal Function Tests & Acute Kidney Injury (AKI) 26m  3.2 - Pancreatic Cancer & Islet Cell Tumors 25m  3.5 - Acquired & Inherited Thrombosis Syndromes 25m • Chapter 5 - Neurodegenerative
 1.2 - Acute Tubular Necrosis (ATN) 16m  5.1 - Alzheimer Disease & Dementia 17m
 1.3 - Tubulointerstitial Nephritis 16m Endocrine 6h 09m Myeloid & Lymphoid 2h 07m  5.2 - Creutzfeldt-Jakob Disease, Parkinson's Disease &
• Chapter 2 - Glomerulopathy • Chapter 1 - Hypothalamic & Pituitary Disorders • Chapter 1 - Myeloid Disorders Huntington's Disease 15m
 2.1 - Nephrotic Syndrome 21m  1.1 - Hypothalamic & Pituitary Dysfunction – Etiologies 12m  1.1 - Myeloproliferative Neoplasms & Myelodysplastic
 2.2 - Nephritic Syndrome 33m  1.2 - Hypothalamic & Pituitary Dysfunction - Clinical Syndromes 18m
• Chapter 3 - Congenital & Chronic Kidney Disease Manifestations 25m  1.2 - AML & CML 19m
 3.1 - Congenital & Cystic Kidney Disease 20m  1.3 - Hyperpituitarism 19m  1.3 - Polycythemia 14m
 3.2 - Chronic Kidney Disease (CKD) 24m  1.4 - Diabetes Insipidus & SIADH 27m • Chapter 2 - Lymphoid & Plasma Cell Disorders
• Chapter 4 - Urinary Tract Obstruction • Chapter 2 - Adrenal Disorders  2.1 - ALL, CLL, Hairy Cell Leukemia & Adult T-cell Leukemia 28m
 4.1 - Hydronephrosis & Urinary Tract Obstruction 18m  2.1 - Adrenal Insufficiency 22m  2.2 - Hodgkin Lymphoma 14m
 4.2 - Calcium Oxalate Stones & Calcium Phosphate Stones 16m  2.2 - Congenital Adrenal Hyperplasia (CAH) 25m  2.3 - Non-Hodgkin Lymphoma 18m
 4.3 - MAP Stones, Uric Acid Stones, & Cystine Stones 11m  2.3 - Adrenocortical Hyperfunction: Hyperaldosteronism &  2.4 - Plasma Cell Neoplasms 16m
• Chapter 5 - Renal Cancer Hypercortisolism 19m
 5.1 - Renal Cell Carcinoma & Nephroblastoma 12m  2.4 - Cushing's Syndrome 22m Immunology 2h 04m
• Chapter 6 - Volume, Electrolyte & Acid/Base Disorders  2.5 - Pheochromocytoma & Neuroblastoma 11m • Chapter 1 - Autoimmune & Amyloidosis
 6.1 - Osmolality & Sodium Disorders 29m • Chapter 3 - Diabetes  1.1 - Autoimmune Disease: Overview & SLE 23m
 6.2 - Potassium Disorders 11m  3.1 - Diabetes Mellitus: Pathogenesis & Acute Clinical  1.2 - Sjogren's Syndrome, Systemic Sclerosis & Mixed
 6.3 - Calcium Disorders 16m Manifestations 29m Connective Tissue Disease 20m
 6.4 - Acid/Base Disorders 31m  3.2 - Diabetic Ketoacidosis (DKA) & Hyperosmolar  1.3 - Polymyositis & Dermatomyositis 9m
 6.5 - Renal Tubular Acidosis (RTA) 19m Hyperglycemic State (HHS) 17m  1.4 - Amyloidosis 15m
 3.3 - Diabetes Mellitus: Chronic Complications 23m • Chapter 2 - Immunodeficiency
• Chapter 4 - Thyroid & Parathyroid  2.1 - B-Cell Disorders & DiGeorge Syndrome 20m
 4.1 - Hypothyroidism: Overview & Hashimoto's Thyroiditis 21m  2.2 - Combined B & T-Cell Disorders 13m
 4.2 - Hypothyroidism: Other Causes 18m  2.3 - Complement System Disorders 7m
 4.3 - Hyperthyroidism: Overview & Graves' Disease 19m  2.4 - Phagocytic Cell Disorders 17m
 4.4 - Thyroid Nodules & Cancer 19m
 4.5 - Parathyroid Gland Disorders 29m
 4.6 - Multiple Endocrine Neoplasia (MEN) 12m